Bronchogen
Experimental Peptide
Bronchogen is the tetrapeptide Ala-Asp-Glu-Leu promoted as a tissue-specific peptide bioregulator. Published evidence is preclinical and does not define a clinical product.
Pharmacokinetic model
A route-level PK model for bronchogen is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Experimental Peptide
- Suggested cadence
- once daily
Research behind this entry
-
Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability
This exact-sequence in-vitro study examined effects on DNA melting behavior. It included no animals or humans and provides no dose, pharmacokinetic, clinical, or safety basis.
1 published study referenced in the app, each with a plain-language summary.